Categories
-
Adhesives
6
Amines
101
Amino Acids
183
Analytical Reagents
713
Antibiotics
255
Bioactive Small Molecules
742
Aroma Chemicals
213
Biochemicals
1049
Boronic Acids
4
Buffers
98
Building Blocks
1927
Carbohydrates
180
Catalysts
111
Chiral Compounds
59
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
262
Flavours and Fragrance Materials
214
Fluorinated Products
51
Furans
6
Gases in Solution
49
Grignard Reagents
26
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
345
Ion-Pair Reagents
24
Ligands
80
Organics
1440
Oxazoles
3
Peptide Reagents
90
Phenols
50
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
57
Pyrimidines
31
Quaternary Ammonium salts
43
Reagents
108
Research Organics & Inorganics
804
Salts
299
Sealing Compounds
1
Sherclin
1
Solvents
127
Stains & Indicators
303
Sugars
64
Tailor-made solutions
1
Testing Standards
4
Uncategorised
33
Water Analysis
13
Clindamycin phosphate
(65529917 | 24729-96-2)
CAS: | 24729-96-2 |
---|---|
Molecular Formula: | C18H34ClN2O8PS |
Molecular Weight: | 504.96 |
Availablility: | In Stock |
---|---|
Downloads: | | |
65529917-25g | 25g | £86.90 | |
Bulk Order |
65529917-25g | 25g | €121.70 | |
Bulk Order |
65529917-25g | 25g | $130.40 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 65529917 | ||||
Product Name | Clindamycin phosphate | ||||
Categories | Antibiotics Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 24729-96-2 | ||||
Molecular Formula | C18H34ClN2O8PS | ||||
Molecular Weight | 504.96 | ||||
Storage Details | -15 to -20 °C | ||||
Harmonised Tariff Code | 2941900000 |
Product Specification
Conclusion | Complies with USP34 the standard. | ||||
Acidity | C=1% (w/v) water solution pH 3.5-4.5 | ||||
Potency | ≥758ug/m | ||||
Water Content (KF) | ≤6.0% | ||||
Bacterial endotoxins | ≤0.58 E.U of endotoxins per milligram | ||||
Appearance | White to off white crystalline powder |
Safety Information
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|